IMMUNE THROMBOCYTOPENIA (ITP)
Clinical trials for IMMUNE THROMBOCYTOPENIA (ITP) explained in plain language.
Never miss a new study
Get alerted when new IMMUNE THROMBOCYTOPENIA (ITP) trials appear
Sign up with your email to follow new studies for IMMUNE THROMBOCYTOPENIA (ITP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill tested to control rare bleeding disorder
Disease control Recruiting nowThis study is testing a new oral medication called pirtobrutinib for adults with immune thrombocytopenia (ITP), a condition where the immune system attacks blood platelets. The first part checks the drug's safety and side effects, while the second part compares different doses to…
Matched conditions: IMMUNE THROMBOCYTOPENIA (ITP)
Phase: PHASE1, PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug combo aims for Longer-Lasting relief in blood platelet disorder
Disease control Recruiting nowThis study is testing if adding a drug called teriflunomide to the standard first treatment (high-dose dexamethasone) works better for adults newly diagnosed with ITP, a condition where the immune system attacks blood platelets. The goal is to see if the combination helps keep pl…
Matched conditions: IMMUNE THROMBOCYTOPENIA (ITP)
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New treatment trial aims to boost platelets in bleeding disorder
Disease control Recruiting nowThis study is testing a new version of an existing treatment called V-IMMUNE for people with immune thrombocytopenia (ITP), a condition where the immune system attacks platelets, increasing the risk of bleeding. The goal is to see if two daily infusions of V-IMMUNE can safely rai…
Matched conditions: IMMUNE THROMBOCYTOPENIA (ITP)
Phase: PHASE3 • Sponsor: On Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New drug trial aims to help teens with rare bleeding disorder
Disease control Recruiting nowThis study is testing a drug called efgartigimod in teenagers (12 to under 18 years old) who have chronic immune thrombocytopenia (ITP), a condition where the immune system attacks blood platelets. The main goal is to find the correct dose and see if it helps increase and maintai…
Matched conditions: IMMUNE THROMBOCYTOPENIA (ITP)
Phase: PHASE2, PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
New drug trial targets stubborn autoimmune blood diseases
Disease control Recruiting nowThis early-stage study is testing an experimental drug called CM336 in adults whose autoimmune blood disorders have not responded to other treatments. The main goals are to see if the drug is safe and if it can help improve patients' blood cell counts. Researchers will monitor fo…
Matched conditions: IMMUNE THROMBOCYTOPENIA (ITP)
Phase: PHASE1, PHASE2 • Sponsor: Keymed Biosciences Co.Ltd • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
New antibody tested for rare bleeding disorder
Disease control Recruiting nowThis early-stage study is testing a new antibody drug called budoprutug in adults with immune thrombocytopenia (ITP), a condition where the immune system attacks platelets. The main goal is to check if the drug is safe and well-tolerated, while also seeing if it helps raise plate…
Matched conditions: IMMUNE THROMBOCYTOPENIA (ITP)
Phase: PHASE1, PHASE2 • Sponsor: Climb Bio, Inc. • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC
-
Radical cell therapy tested for Tough-to-Treat autoimmune illnesses
Disease control Recruiting nowThis early-stage study is testing the safety and initial effectiveness of a new cell therapy called BZE2204 for adults with severe autoimmune diseases that have not improved with standard treatments. The therapy involves modifying a patient's own immune cells to target and potent…
Matched conditions: IMMUNE THROMBOCYTOPENIA (ITP)
Phase: EARLY_PHASE1 • Sponsor: Shanghai Cell Therapy Group Co.,Ltd • Aim: Disease control
Last updated Mar 06, 2026 15:39 UTC
-
New drug trial offers hope for patients with stubborn blood disorder
Disease control Recruiting nowThis study is testing whether an experimental drug called DZD8586 can safely increase platelet counts in adults with immune thrombocytopenia (ITP) who haven't responded well to standard treatments. The trial will enroll 60 participants who will receive different doses of the medi…
Matched conditions: IMMUNE THROMBOCYTOPENIA (ITP)
Phase: PHASE2 • Sponsor: Dizal Pharmaceuticals • Aim: Disease control
Last updated Mar 02, 2026 15:28 UTC